HTA's and access to rare diseases therapies: The view from the PID community

Saved in:
Bibliographic Details
Published in:Pharmaceuticals policy and law 2011, Vol.13 (3,4), p.177-181
Main Authors: Prevot, J., Watters, D.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 181
container_issue 3,4
container_start_page 177
container_title Pharmaceuticals policy and law
container_volume 13
creator Prevot, J.
Watters, D.
description
doi_str_mv 10.3233/PPL-2011-0322
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3233_PPL_2011_0322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3233_PPL_2011_0322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c108t-bf4c0e2e9d752f85601fa65abd5ea11d5ce86470cbdee9184d439817db15b4673</originalsourceid><addsrcrecordid>eNotz8FLwzAYBfAcFJzTo_fcPEXzJU2beBtTt0HBHuo5pMkXVrHrSKqy_94VPT14Dx78CLkD_iCFlI9NUzPBARiXQlyQBUhtmNCiuiLXOX9wLqCUZkHqbbu6z9QdAnXeY850GmlyCWnoM7qM52KPyR17zE-03SP97vGHxjQO80Cb3TP14zB8HfrpdEMuo_vMePufS_L--tKut6x-2-zWq5p54HpiXSw8R4EmVEpErUoO0ZXKdUGhAwjKoy6LivsuIBrQRSik0VCFDlRXlJVcEvb369OYc8Joj6kfXDpZ4Hbm2zPfznw78-UvwLJO2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>HTA's and access to rare diseases therapies: The view from the PID community</title><source>Access via Business Source (EBSCOhost)</source><creator>Prevot, J. ; Watters, D.</creator><creatorcontrib>Prevot, J. ; Watters, D.</creatorcontrib><identifier>ISSN: 1389-2827</identifier><identifier>DOI: 10.3233/PPL-2011-0322</identifier><language>eng</language><ispartof>Pharmaceuticals policy and law, 2011, Vol.13 (3,4), p.177-181</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>Prevot, J.</creatorcontrib><creatorcontrib>Watters, D.</creatorcontrib><title>HTA's and access to rare diseases therapies: The view from the PID community</title><title>Pharmaceuticals policy and law</title><issn>1389-2827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNotz8FLwzAYBfAcFJzTo_fcPEXzJU2beBtTt0HBHuo5pMkXVrHrSKqy_94VPT14Dx78CLkD_iCFlI9NUzPBARiXQlyQBUhtmNCiuiLXOX9wLqCUZkHqbbu6z9QdAnXeY850GmlyCWnoM7qM52KPyR17zE-03SP97vGHxjQO80Cb3TP14zB8HfrpdEMuo_vMePufS_L--tKut6x-2-zWq5p54HpiXSw8R4EmVEpErUoO0ZXKdUGhAwjKoy6LivsuIBrQRSik0VCFDlRXlJVcEvb369OYc8Joj6kfXDpZ4Hbm2zPfznw78-UvwLJO2A</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Prevot, J.</creator><creator>Watters, D.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2011</creationdate><title>HTA's and access to rare diseases therapies: The view from the PID community</title><author>Prevot, J. ; Watters, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c108t-bf4c0e2e9d752f85601fa65abd5ea11d5ce86470cbdee9184d439817db15b4673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prevot, J.</creatorcontrib><creatorcontrib>Watters, D.</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmaceuticals policy and law</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prevot, J.</au><au>Watters, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HTA's and access to rare diseases therapies: The view from the PID community</atitle><jtitle>Pharmaceuticals policy and law</jtitle><date>2011</date><risdate>2011</risdate><volume>13</volume><issue>3,4</issue><spage>177</spage><epage>181</epage><pages>177-181</pages><issn>1389-2827</issn><doi>10.3233/PPL-2011-0322</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1389-2827
ispartof Pharmaceuticals policy and law, 2011, Vol.13 (3,4), p.177-181
issn 1389-2827
language eng
recordid cdi_crossref_primary_10_3233_PPL_2011_0322
source Access via Business Source (EBSCOhost)
title HTA's and access to rare diseases therapies: The view from the PID community
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T19%3A34%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HTA's%20and%20access%20to%20rare%20diseases%20therapies:%20The%20view%20from%20the%20PID%20community&rft.jtitle=Pharmaceuticals%20policy%20and%20law&rft.au=Prevot,%20J.&rft.date=2011&rft.volume=13&rft.issue=3,4&rft.spage=177&rft.epage=181&rft.pages=177-181&rft.issn=1389-2827&rft_id=info:doi/10.3233/PPL-2011-0322&rft_dat=%3Ccrossref%3E10_3233_PPL_2011_0322%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c108t-bf4c0e2e9d752f85601fa65abd5ea11d5ce86470cbdee9184d439817db15b4673%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true